U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


ABERCROMBIE GEORGE B (0001485939)
Mailing Address
C/O INSPIRE PHARMACEUTICALS, INC.
4222 EMPEROR BLVD., SUITE 200
DURHAM NC 27703
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Brickell Biotech, Inc.
Current Name:Fresh Tracks Therapeutics, Inc.
0000819050 2019-08-31 director
Innoviva, Inc. 0001080014 2014-06-02 officer: Sr. VP, Corp. Partnerships
BIOCRYST PHARMACEUTICALS INC 0000882796 2011-10-10 director
Ocera Therapeutics, Inc. 0001274644 2011-09-19 director
ZIOPHARM ONCOLOGY INC
Current Name:Alaunos Therapeutics, Inc.
0001107421 2010-04-05 director
INSPIRE PHARMACEUTICALS INC 0001040416 2010-03-01 director


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-06-12   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 6820.0000 36431.0000 1 0000882796 Common Stock
A 2024-06-12   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 49933.0000 49933.0000 2 0000882796 Automatic Stock Option Grant
A 2023-06-13   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 16745.0000 29611.0000 1 0000882796 Common Stock
A 2023-06-13   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 39072.0000 39072.0000 2 0000882796 Automatic Stock Option Grant
A 2022-06-07   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 12866.0000 12866.0000 1 0000882796 Common Stock
A 2022-06-07   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 30022.0000 30022.0000 2 0000882796 Automatic Stock Option Grant
A 2022-04-18   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 5000.0000 1 0000882796 Common Stock
D 2022-04-18   BIOCRYST PHARMACEUTICALS INC 4 S-Sale --D 5000.0000 0.0000 2 0000882796 Common Stock
D 2022-04-18   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 0.0000 3 0000882796 Automatic Stock Option Grant
A 2022-02-15   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 5000.0000 1 0000882796 Common Stock
D 2022-02-15   BIOCRYST PHARMACEUTICALS INC 4 S-Sale --D 5000.0000 0.0000 2 0000882796 Common Stock
D 2022-02-15   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 5000.0000 3 0000882796 Automatic Stock Option Grant
A 2021-11-15   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 5000.0000 1 0000882796 Common Stock
D 2021-11-15   BIOCRYST PHARMACEUTICALS INC 4 S-Sale --D 5000.0000 0.0000 2 0000882796 Common Stock
D 2021-11-15   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 10000.0000 3 0000882796 Automatic Stock Option Grant
A 2021-09-15   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 5000.0000 1 0000882796 Common Stock
D 2021-09-15   BIOCRYST PHARMACEUTICALS INC 4 S-Sale --D 5000.0000 0.0000 2 0000882796 Common Stock
D 2021-09-15   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 0.0000 3 0000882796 Non-Qualified Stock Option
A 2021-09-10   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 11000.0000 14000.0000 1 0000882796 Common Stock
A 2021-09-10   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 30000.0000 44000.0000 2 0000882796 Common Stock
A 2021-09-10   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 30000.0000 74000.0000 3 0000882796 Common Stock
D 2021-09-10   BIOCRYST PHARMACEUTICALS INC 4 S-Sale --D 74000.0000 0.0000 4 0000882796 Common Stock
D 2021-09-10   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 11000.0000 0.0000 5 0000882796 Automatic Stock Option Grant
D 2021-09-10   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 30000.0000 0.0000 6 0000882796 Automatic Stock Option Grant
D 2021-09-10   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 30000.0000 0.0000 7 0000882796 Automatic Stock Option Grant
A 2021-07-15   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 8000.0000 1 0000882796 Common Stock
D 2021-07-15   BIOCRYST PHARMACEUTICALS INC 4 S-Sale --D 5000.0000 3000.0000 2 0000882796 Common Stock
D 2021-07-15   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 5000.0000 5000.0000 3 0000882796 Non-Qualified Stock Option
A 2021-05-25   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 40000.0000 40000.0000 1 0000882796 Automatic Stock Option Grant
A 2021-05-24   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 6667.0000 9667.0000 1 0000882796 Common Stock
D 2021-05-24   BIOCRYST PHARMACEUTICALS INC 4 S-Sale --D 6667.0000 3000.0000 2 0000882796 Common Stock
D 2021-05-24   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 6667.0000 10000.0000 3 0000882796 Non-Qualified Stock Option
D 2021-05-10   BIOCRYST PHARMACEUTICALS INC 4 S-Sale --D 7000.0000 3000.0000 1 0000882796 Common Stock
A 2020-05-12   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 40000.0000 40000.0000 1 0000882796 Automatic Stock Option Grant
A 2020-02-14   Brickell Biotech, Inc. 4 A-Award --D 2167.0000 2167.0000 12 0000819050 Restricted Stock Units
A 2020-02-14   Brickell Biotech, Inc. 4 A-Award --D 8764.0000 8764.0000 13 0000819050 Stock Options
A 2019-05-29   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 30000.0000 30000.0000 1 0000882796 Automatic Stock Option Grant
D 2018-08-21   Innoviva, Inc. 4 S-Sale --D 8000.0000 285479.0000 2 0001080014 Common Stock
D 2018-08-20   Innoviva, Inc. 4 F-InKind --D 5680.0000 293479.0000 1 0001080014 Common Stock
A 2018-06-20   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 30000.0000 30000.0000 1 0000882796 Automatic Stock Option Grant
D 2018-05-21   Innoviva, Inc. 4 S-Sale --D 8000.0000 299159.0000 2 0001080014 Common Stock
D 2018-05-20   Innoviva, Inc. 4 F-InKind --D 4682.0000 305235.0000 1 0001080014 Common Stock
A 2018-03-02   Innoviva, Inc. 4 A-Award --D 74444.0000 309917.0000 1 0001080014 Common Stock
D 2018-02-21   Innoviva, Inc. 4 S-Sale --D 8000.0000 235473.0000 2 0001080014 Common Stock
D 2018-02-20   Innoviva, Inc. 4 F-InKind --D 15500.0000 243473.0000 1 0001080014 Common Stock
D 2017-11-21   Innoviva, Inc. 4 S-Sale --D 5215.0000 258651.0000 2 0001080014 Common Stock
D 2017-11-20   Innoviva, Inc. 4 F-InKind --D 3358.0000 263866.0000 1 0001080014 Common Stock
D 2017-08-20   Innoviva, Inc. 4 F-InKind --D 2886.0000 267224.0000 1 0001080014 Common Stock
A 2017-05-24   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 30000.0000 30000.0000 1 0000882796 Automatic Stock Option Grant
D 2017-05-20   Innoviva, Inc. 4 F-InKind --D 2228.0000 270110.0000 1 0001080014 Common Stock
D 2017-02-20   Innoviva, Inc. 4 F-InKind --D 5355.0000 269838.0000 1 0001080014 Common Stock
A 2017-01-17   Innoviva, Inc. 4 A-Award --D 106718.0000 275193.0000 1 0001080014 Common Stock
D 2016-11-20   Innoviva, Inc. 4 F-InKind --D 1273.0000 168475.0000 1 0001080014 Common Stock
D 2016-08-20   Innoviva, Inc. 4 F-InKind --D 1939.0000 169463.0000 1 0001080014 Common Stock
A 2016-05-23   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 30000.0000 30000.0000 1 0000882796 Automatic Stock Option Grant
D 2016-05-20   Innoviva, Inc. 4 F-InKind --D 1276.0000 171402.0000 1 0001080014 Common Stock
D 2016-02-19   Innoviva, Inc. 4 F-InKind --D 5376.0000 170178.0000 1 0001080014 Common Stock
A 2016-01-14   Innoviva, Inc. 4 A-Award --D 92587.0000 175554.0000 1 0001080014 Common Stock
A 2015-05-20   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 15000.0000 15000.0000 1 0000882796 Automatic Stock Option Grant
A 2015-01-07   THERAVANCE INC 4 A-Award --D 71429.0000 81429.0000 1 0001080014 Common Stock
A 2014-06-19   THERAVANCE INC 4 A-Award --D 10000.0000 10000.0000 1 0001080014 Common Stock
A 2014-06-19   THERAVANCE INC 4 A-Award --D 100000.0000 100000.0000 2 0001080014 Stock Option Grant (Right to Buy)
A 2014-05-02   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 15000.0000 15000.0000 1 0000882796 Automatic Stock Option Grant
A 2014-03-31   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 4000.0000 10000.0000 1 0000882796 Common Stock
D 2014-03-31   BIOCRYST PHARMACEUTICALS INC 4 M-Exempt --D 4000.0000 11000.0000 2 0000882796 Automatic Stock Option Grant
A 2013-11-12   BIOCRYST PHARMACEUTICALS INC 4 P-Purchase --D 3000.0000 6000.0000 1 0000882796 Common Stock
A 2013-05-31   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 15000.0000 15000.0000 1 0000882796 Automatic Stock Option Grant
A 2013-03-05   BIOCRYST PHARMACEUTICALS INC 4 P-Purchase --D 3000.0000 3000.0000 1 0000882796 Common Stock
A 2012-08-07   TRANZYME INC 4 A-Award --D 31835.0000 31835.0000 1 0001274644 Stock Option (Right to Buy)
A 2012-05-23   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 15000.0000 15000.0000 1 0000882796 Automatic Stock Option Grant
A 2011-10-18   TRANZYME INC 4 A-Award --D 25000.0000 25000.0000 1 0001274644 Stock Option (Right to Buy)
A 2011-10-18   TRANZYME INC 4/A A-Award --D 25000.0000 25000.0000 1 0001274644 Stock Option (Right to Buy)
A 2011-10-10   BIOCRYST PHARMACEUTICALS INC 4 A-Award --D 16667.0000 16667.0000 1 0000882796 Non-Qualified Stock Option
D 2011-05-13   INSPIRE PHARMACEUTICALS INC 4 U-Tender --D 1099.0000 0.0000 1 0001040416 Common Stock
D 2011-05-13   INSPIRE PHARMACEUTICALS INC 4 D-Return --D 10164.0000 0.0000 2 0001040416 Stock Option (Right to Buy)
D 2011-05-13   INSPIRE PHARMACEUTICALS INC 4 D-Return --D 18970.0000 0.0000 3 0001040416 Stock Option (Right to Buy)
D 2011-05-13   INSPIRE PHARMACEUTICALS INC 4 D-Return --D 2371.0000 0.0000 4 0001040416 Stock Option (Right to Buy)
D 2011-05-13   INSPIRE PHARMACEUTICALS INC 4 D-Return --D 6873.0000 0.0000 5 0001040416 Restricted Stock Unit
D 2011-05-13   INSPIRE PHARMACEUTICALS INC 4 D-Return --D 12739.0000 0.0000 6 0001040416 Restricted Stock Unit
A 2010-06-03   INSPIRE PHARMACEUTICALS INC 4 M-Exempt --D 1592.0000 1592.0000 1 0001040416 Common Stock

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016